3rd Quarter - Report

CONTINENTAL STRATEGY, LLC for IMMIX BIOPHARMA, INC.

Firm
Client
Income
$105,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

FDA approval standards

LobbyistCovered position, as disclosed
TIMOTHY COSTA New Former Chief of Staff to Dan Meuser
LUKE NICKLESS Senior Policy Advisor, Appropriations, House Committee on the Budget

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.